skylark trial update: isa-krd in newly diagnosed, transplant-eligible multiple myeloma
Published 10 months ago • 100 plays • Length 0:38Download video MP4
Download video MP3
Similar videos
-
2:17
skylark: phase ii study of isa-krd in newly diagnosed, transplant-eligible multiple myeloma
-
2:04
isatuximab, carfilzomib, lenalidomide, and dexamethasone in multiple myeloma: the skylark trial
-
5:17
gmmg-concept: isa-krd in front-line treatment of high-risk myeloma
-
6:11
phase ii mrd-adaptive trial of elo-krd for newly diagnosed myeloma
-
1:19
results of the perseus trial: d-vrd with d-r maintenance in transplant-eligible newly diagnosed mm
-
4:01
kenneth anderson: what are the next steps to a myeloma cure?
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma
-
4:06
treating newly-diagnosed myeloma
-
2:44
myeloma qol through induction and maintenance
-
1:59
the growing importance of celmods in the treatment of r/r multiple myeloma
-
1:59
novel approaches in newly diagnosed myeloma
-
1:01
car-t: myeloma toxicities
-
2:46
managing patients with high-risk myeloma
-
1:53
the future of multiple myeloma treatment
-
4:26
the prognostic value of peripheral blood mrd status following elo-krd in newly diagnosed myeloma
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
1:21
what is the pcrowd study, and how does knowledge in myeloma biology help with new treatments?
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline